Nutriop

The Sheekey Science Show – Precision Medicine

Latest articles

Dyno Therapeutics closes $100m to accelerate gene therapy

Dyno Therapeutics closes $100 million Series A led by Andreessen Horowitz to accelerate AI-powered gene therapy platform. Dyno Therapeutics, Inc, a biotech applying AI to...

Sticking with glutathione could be a smart longevity choice

The body's "master antioxidant" glutathione is a powerful weapon in the fight for longevity, but it diminishes with age; AgelessRx has a range of...

Rise of the retrons – a new gene editing technique

Move over CRISPR... a new gene editing technique enables millions of genetic experiments to be performed simultaneously. Like the best B Movie ever, The Day...

VitaDAO announces “Longevity Molecule” research project

VitaDAO will use advanced machine learning to crunch the data from 1.04 billion prescriptions to understand the impact of drugs on human lifespan. VitaDAO, which...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Dyno Therapeutics closes $100m to accelerate gene therapy

Dyno Therapeutics closes $100 million Series A led by Andreessen Horowitz to accelerate AI-powered gene therapy platform. Dyno Therapeutics, Inc, a biotech applying AI to...

Sticking with glutathione could be a smart longevity choice

The body's "master antioxidant" glutathione is a powerful weapon in the fight for longevity, but it diminishes with age; AgelessRx has a range of...

Rise of the retrons – a new gene editing technique

Move over CRISPR... a new gene editing technique enables millions of genetic experiments to be performed simultaneously. Like the best B Movie ever, The Day...
Nutriop

What to expect for Precision medicine by 2030?

All of us are unique. What may good for one persons health may be terrible for another’s. So how do we account for these differences to optimize health for all? Well, precision medicine aims to takes into account an individuals variability in genes, environment and lifestyle to provide refined diagnoses, more rational treatment options with the overall aim of preventing disease and optimising health.

Sheekey Science

So, what can we expect for the future of medicine by 2030? Outlined in this video are seven areas where there is great opportunity for achieving precision medicine.

Sheekey Science

This includes improving diversity in studies, better managing large data sets and gathering more high quality data that can be acquired both in healthcare settings and through wearable devices, integrating and interpreting this data using artificial intelligence (notably deep neural networks) and ensuring that the data is kept safe and secure using blockchain technology.

Sheekey Science

And most importantly, making sure the output health advice will improve the health of the patient.

Sheekey Science

Whilst there are many challenges ahead for achieving precision medicine, acknowledging these issues now will enable the development of strategies to overcome them to enhance the efficacy of precision medicine.

Sheekey Science

Watch more Sheekey Science videos here.

Image credit: FormatPexels

Comment on this article

Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.
Nutriop

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
Supplement report

Related articles

Anxiety can affect your health – here’s what do to about it

Chronic anxiety can not only interfere with your quality of life, but it can affect your lifespan and your health. Find out why. Mental Health...

Epigenetics – or why you are more than just your genes

Many companies now offer solutions to help you measure your epigenetic age, but what does it all mean and how do these tests work? Ever...

Understanding your metabolism could help your healthspan

Metabolism is pretty misunderstood, but finding out more about yours could pave the way to a better healthspan. "When I was younger I could eat...

Can micromovements help you live longer?

It sounds like a toddler’s exercise group, but micromovements can hold the key to a longer, and healthier lifestyle. Here’s how. The world we live...

Everything you need to know about spermidine…

...but were afraid to ask! Its name will raise a few eyebrows, but this simple ingredient is turning out to have some remarkable benefits...
Supps report ad middle